Nektar Therapeutics buy BiotechBee
Start price
14.09.25
/
70%
€40.80
Target price
28.11.27
€100.00
Performance (%)
-0.49%
End price
15.09.25
€40.60
Summary
This prediction ended on 15.09.25 with a price of €40.60. During the runtime of the prediction for Nektar Therapeutics the price only changed by -0.49%. BiotechBee has a follow-up prediction for Nektar Therapeutics where he still thinks Nektar Therapeutics is a Buy. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Nektar Therapeutics | - | - |
| iShares Core DAX® | 0.437% | 5.897% |
| iShares Nasdaq 100 | 1.057% | 0.920% |
| iShares Nikkei 225® | 1.769% | 1.228% |
| iShares S&P 500 | 0.368% | 1.920% |
According to BiotechBee what are the pros and cons of Nektar Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Nektar Therapeutics diskutieren
Buy mit Kursziel 100,0
In the thread Trading Nektar Therapeutics
Current prediction by BiotechBee for Nektar Therapeutics
Nektar Therapeutics
Start price
Target price
Perf. (%)
€60.20
03.08.26
03.08.26
€110.00
31.07.28
31.07.28
2.82%
09:31
09:31
Could be very worthwhile Investment >20% year
